BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3989820)

  • 1. Effect of structural modification of the hydantoin ring on anticonvulsant activity.
    Cortes S; Liao ZK; Watson D; Kohn H
    J Med Chem; 1985 May; 28(5):601-6. PubMed ID: 3989820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized DL-amino acid derivatives. Potent new agents for the treatment of epilepsy.
    Conley JD; Kohn H
    J Med Chem; 1987 Mar; 30(3):567-74. PubMed ID: 3820228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
    Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
    Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anticonvulsant activity of some amino acid derivatives. Part 2: Derivatives of Gly, Ala, Leu, Pro, Trp, Phe(4 Cl), Ala(alpha-Me).
    Paruszewski R; Rostafinska-Suchar G; Strupinska M; Jaworski P; Winiecka I; Stables JP
    Pharmazie; 1996 Apr; 51(4):212-5. PubMed ID: 8628738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticonvulsant activity of some 4-methoxy- and 4-chlorobenzanilides.
    Clark CR; McMillian CL
    J Pharm Sci; 1990 Mar; 79(3):220-2. PubMed ID: 2338630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoalkanolic derivatives of xanthone with potential antiepileptic activity.
    Marona H; Górka Z; Szneler E
    Pharmazie; 1998 Apr; 53(4):219-23. PubMed ID: 9583083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsants. 5. Derivatives of 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin.
    Vida JA; O'Dea MH; Samour CM; Reinhard JF
    J Med Chem; 1975 Apr; 18(4):383-5. PubMed ID: 1121005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of new antiepileptics. II. Anticonvulsant effect of hydantoin derivatives].
    Waser PG; Ganz AJ; Pfirrmann RW
    Arzneimittelforschung; 1977; 27(11):2125-8. PubMed ID: 580013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant activity of 2-(substituted-imino)thiazolidin-4-ones.
    Gong GH; Wang D; Zhang JF; Wei CX; Quan ZS
    Drug Res (Stuttg); 2014 Jan; 64(1):5-9. PubMed ID: 23955391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant properties of 3-oxo- and 3-imino-4-substituted 1,2,5-thiadiazolidine 1,1-dioxides.
    Lee CH; Kohn H
    J Pharm Sci; 1990 Aug; 79(8):716-8. PubMed ID: 2231335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 8-alkoxy-4,5-dihydro-[1,2,4]triazole[4,3-a]quinoline-1-ones and evaluation of their anticonvulsant properties.
    Sun XY; Jin YZ; Li FN; Li G; Chai KY; Quan ZS
    Arch Pharm Res; 2006 Dec; 29(12):1080-5. PubMed ID: 17225454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential anticonvulsants. 11. Synthesis and anticonvulsant activity of spiro[1,3-dioxolane-2,3'-indolin]-2'-ones and structural analogues.
    Rajopadhye M; Popp FD
    J Med Chem; 1988 May; 31(5):1001-5. PubMed ID: 3361568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anticonvulsant activity of some amino acid derivatives. Part 1: alanine derivatives.
    Paruszewski R; Rostafinska-Suchar G; Strupinska M; Jaworski P; Stables JP
    Pharmazie; 1996 Mar; 51(3):145-8. PubMed ID: 8900864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 9-alkoxy-6,7-dihydro-5H-benzo[c] [1,2,4]triazolo[4,3-a]azepines as potential anticonvulsant agents.
    Piao FY; Peng B; Zhang WB; Zhang W; Han RB
    Arzneimittelforschung; 2012 Apr; 62(4):202-7. PubMed ID: 22286977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of some 2/3-benzoylaminopropionanilide derivatives.
    Uysal S; Calis U; Soyer Z
    Arzneimittelforschung; 2012 Jun; 62(6):295-300. PubMed ID: 22473524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Evaluation of Novel Diazaspiro Hydantoins as Potential Anticonvulsants.
    Kumar CSA; Veeresh B; Ramesha KC; Raj CSA; Mahadevaiah KM; Prasad SBB
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):201-208. PubMed ID: 28707581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anticonvulsant activity of new kojic acid derivatives.
    Aytemir MD; Septioğlu E; Caliş U
    Arzneimittelforschung; 2010; 60(1):22-9. PubMed ID: 20184223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 3,4-dihydro-4-oxoquinazoline derivatives as potential anticonvulsants.
    Vaidya NA; Panos CH; Kite A; Iturrian WB; Blanton CD
    J Med Chem; 1983 Oct; 26(10):1422-5. PubMed ID: 6620301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives.
    Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W
    Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.